TIRZEPATIDE

GLP-1

GIP

$299.00

Tirzepatide + B12 is a once-weekly injectable medication formulation that targets both GLP-1 and GIP receptors to support blood sugar regulation, enhance insulin sensitivity, and promote weight loss. It helps reduce appetite, slow gastric emptying, and improve metabolic flexibility, making it one of the most effective tools for long-term fat loss and metabolic health support. This formulation is compounded with B12, for a total vial content of 20mg Tirzepatide + 4mg B12 (labeled as 5mg Tirzepatide + 1mg B12 per 0.5mL in a 2mL vial). Note: Compounded with B12 for enhanced energy, metabolic support, and reduced injection site discomfort. The pink color is normal.

START NOW

MECHANISM OF ACTION: Tirzepatide activates the GLP-1 and GIP pathways to regulate glucose levels, suppress appetite, delay gastric emptying, and stimulate insulin secretion. The dual action increases energy efficiency and reduces fat storage while promoting satiety and metabolic reprogramming.

Increased weight loss and reduced visceral fat
Improved blood glucose and insulin sensitivity
Appetite suppression and reduced food cravings
Cardiometabolic protection and inflammation reduction
Improved energy, satiety, and long-term metabolic regulation

TOTAL CONTENT: 20mg Tirzepatide + 4mg B12
CONCENTRATION: 5mg/1mg/0.5ml
VIAL SIZE: 2ml
SUPPLY: 8-16 weeks (dose dependent)
STORAGE: Refrigerate at 36–46°F (2–8°C). Do not freeze.

Mild injection site redness or discomfort
Nausea, constipation, or diarrhea (common early)
Decreased appetite or food aversion
Vomiting or delayed gastric emptying (rare)

Active cancer
Pregnancy or breastfeeding
Known hypersensitivity to any medication components

This therapy should be used under the guidance of a healthcare provider. If you experience any of the following, discontinue use and contact us immediately: